← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2016Last known activity
Jan 2, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 8 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT06525155Sponsor investigatorPhase 3Jan 2, 2024
- NCT06525155OfficialPhase 3Jan 2, 2024
- NCT06525155Lead sponsorPhase 3Jan 2, 2024
- NCT05887804Lead sponsorPhase 4Oct 1, 2021
- NCT05939817Lead sponsorPhase 4Oct 1, 2021
- NCT05007496Overall official - principal investigatorPhase 2Apr 14, 2021
- NCT04685603Overall official - principal investigatorPhase 1Dec 7, 2020
- NCT04407208CollaboratorPhase 1May 1, 2020
- NCT04105504Sponsor investigatorPhase 1Apr 8, 2018
- NCT04105504Lead sponsorPhase 1Apr 8, 2018
- NCT03626298Reponsible party - principal investigatorPhase 4Aug 1, 2016
- NCT03626298Lead sponsorPhase 4Aug 1, 2016
Details
- Last known activity
- Jan 2, 2024